SMITH STAN purchased 1.5% of their position (19.23K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $25.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/2/2025ACC: 0001878313-25-000019
+38.46K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
38.46K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+19.23K
Price / share
$1.30
Trade value
$25K
% of position
1.5%
10/1/2025
1.31M→1.32M
Total
Net shares
+19.23K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/1/2025 | P · Purchase | +19.23K | $1.30 | $25K | 1.5% | 1.31M | 1.32M |
| Total | +19.23K | $25K | ||||||
Derivative Transactions1
Warrants
Indirect
Converts to
Common Stock
19.23K shares
Shares
+19.23K
Strike price
1.57
Held after
19.23K
Exercisable
—
10/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock19.23K shares | 10/1/2025 | P · Purchase | +19.23K | 1.57 | — | 19.23K |